These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6142724)

  • 1. Binding potencies of 3 new beta 2 specific blockers to beta receptors in the ciliary processes and the possible relevance of these drugs to intraocular pressure control.
    Trope GE; Clark B
    Br J Ophthalmol; 1984 Apr; 68(4):245-7. PubMed ID: 6142724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta adrenergic receptors in pigmented ciliary processes.
    Trope GE; Clark B
    Br J Ophthalmol; 1982 Dec; 66(12):788-92. PubMed ID: 6293532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of beta adrenergic receptors in human and rabbit ciliary process and heart.
    Nathanson JA
    J Pharmacol Exp Ther; 1985 Jan; 232(1):119-26. PubMed ID: 2856938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of beta adrenergic receptors in bovine pigmented ciliary processes.
    Elena PP; Moulin G; Lapalus P
    Curr Eye Res; 1984 May; 3(5):743-50. PubMed ID: 6145543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between hydrophobicity and beta-blocking potencies, affinities or dissociation of beta-blockers from beta-adrenoceptors.
    Nakamura T; Hosohata Y; Hosohata K; Hattori K; Suzuki J; Nagatomo T
    Res Commun Mol Pathol Pharmacol; 1999; 106(3):203-11. PubMed ID: 11485050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta adrenergic blocking agents for open-angle glaucoma.
    Lee ME
    J Am Optom Assoc; 1988 Jul; 59(7):567-71. PubMed ID: 2900260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the beta-blockers timolol and H 216/44 to ocular melanin.
    Abrahamsson T; Boström S; Bräutigam J; Lagerström PO; Regårdh CG; Vauqelin G
    Exp Eye Res; 1988 Oct; 47(4):565-77. PubMed ID: 2903066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body.
    Wax MB; Molinoff PB
    Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):420-30. PubMed ID: 3030954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]CGP-12177 binding to beta-adrenoceptors of intact bovine mononuclear leukocytes.
    Vermeir M; Roets E; Burvenich C
    Arch Int Pharmacodyn Ther; 1993; 321():103-11. PubMed ID: 8100703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
    Phan TM; Nguyen KP; Giacomini JC; Lee DA
    J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process.
    Nathanson JA
    J Pharmacol Exp Ther; 1988 Apr; 245(1):94-101. PubMed ID: 2896241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro determination of the ability of drugs to bind to adrenergic receptors.
    Neufeld AH; Page ED
    Invest Ophthalmol Vis Sci; 1977 Dec; 16(12):1118-24. PubMed ID: 200584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta blockers in open angle glaucoma.
    Marmion VJ
    Indian J Ophthalmol; 1982 Jul; 30(4):229-31. PubMed ID: 6131867
    [No Abstract]   [Full Text] [Related]  

  • 15. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor binding potencies of new aliphatic and alicyclic oxime ethers and their relevance to intraocular pressure control.
    Himber J; Velly J; Kintz P; de Burlet G; Andermann G; Leclerc G
    Methods Find Exp Clin Pharmacol; 1989 May; 11(5):315-21. PubMed ID: 2547127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular effect and intraocular pressure-reducing effect of beta blockers].
    Merté HJ
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):396-7. PubMed ID: 2879957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological effects of topical timolol in the rabbit eye.
    Bartels SP; Roth HO; Jumblatt MM; Neufeld AH
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1189-97. PubMed ID: 6106643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the beta-adrenergic receptor-binding agent 'timolol' in the treatment of open-angle glaucoma.
    Strempel I
    Ophthalmologica; 1982; 184(4):198-203. PubMed ID: 6122193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two new beta-blockers for glaucoma.
    Med Lett Drugs Ther; 1986 Apr; 28(712):45-6. PubMed ID: 2870417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.